Circulation

Vol. 151, Issue 4 Issue 4 2025
10
Articles

Articles in this Issue

Relatively Increased CO <sub>2</sub> Delivered to the Brain From the Descending Aorta Leading to an Elevated Respiratory Rate Causing Differential Hypocapnia (RIDDLER or East-West Syndrome): New Pitfalls in Awake Peripheral V-A ECMO

Alex Rosenberg, Louit Thakuria, Christophe Vandenbriele Jan 28, 2025 pp. 289-291 10.1161/circulationaha.124.071524

Performance and Safety of the Extravascular Implantable Cardioverter Defibrillator Through Long-Term Follow-Up: Final Results From the Pivotal Study

Paul Friedman, Francis Murgatroyd, Lucas V.A. Boersma et al. Jan 28, 2025 pp. 322-332 10.1161/circulationaha.124.071795

BACKGROUND: Substernal lead placement of the extravascular implantable cardioverter defibrillator (EV ICD) permits both defibrillation at thresholds similar to those seen with transvenous...

Kidney Decline Predicts Worse Heart Failure Outcomes

Bridget M. Kuehn Jan 28, 2025 pp. 348-350 10.1161/circulationaha.124.072099

Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol–Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis

Harpreet S. Bhatia, Simon Wandel, Peter Willeit et al. Jan 28, 2025 pp. 312-321 10.1161/circulationaha.124.069556

BACKGROUND: Low-density lipoprotein cholesterol (LDL-C) and lipoprotein(a) (Lp[a]) levels are independently associated with atherosclerotic cardiovascular disease (ASCVD). However, the rel...

Targeting Sphingosine-1-Phosphate Signaling to Prevent the Progression of Aortic Valve Disease

Marcel Benkhoff, Maike Barcik, Philipp Mourikis et al. Jan 28, 2025 pp. 333-347 10.1161/circulationaha.123.067270

BACKGROUND: Aortic valve disease (AVD) is associated with high mortality and morbidity. To date, there is no pharmacological therapy available to prevent AVD progression. Because valve cal...

Cardiorespiratory Fitness Assessment in Stem Cell Transplant Recipients: Getting to the Heart of the Problem

Justin M. Canada Jan 28, 2025 pp. 309-311 10.1161/circulationaha.124.072547

Letter by Yan et al Regarding Article, “Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults With Pulmonary Arterial Hypertension”

Peijing Yan, Min Zhang, YUNSHAN CAO Jan 28, 2025 10.1161/circulationaha.124.071712

SLICE-CEA CardioLink-8: A Randomized Trial of Evolocumab on Carotid Artery Atherosclerotic Plaque Characteristics in Asymptomatic High-Risk Carotid Stenosis

C. David Mazer, Alan R. Moody, Hwee Teoh et al. Jan 28, 2025 pp. 351-355 10.1161/circulationaha.124.072285

Response by Hoeper et al to Letter Regarding Article, “Randomized, Multicenter Study to Assess the Effects of Different Doses of Sildenafil on Mortality in Adults with Pulmonary Arterial Hypertension”

Marius M. Hoeper, Scott Haughie, Tarek Hassan et al. Jan 28, 2025 10.1161/circulationaha.124.072235

Preventing Allogeneic Stem Cell Transplant–Related Cardiovascular Dysfunction: ALLO-Active Trial

Hayley T. Dillon, Nicholas J. Saner, Tegan Ilsley et al. Jan 28, 2025 pp. 292-308 10.1161/circulationaha.124.070709

BACKGROUND: Allogeneic stem cell transplantation (allo-SCT) is an efficacious treatment for hematologic malignancies but can be complicated by cardiac dysfunction and exercise intolerance...

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0009-7322
E-ISSN 1524-4539
Subject Health Sciences
Language English
View Full Journal Page